Atezolizumab did not improve overall survival, progression-free survival, distant metastasis-free survival, or time to local failure.

Researchers sought to determine whether combination decitabine, venetoclax, and ponatinib would be effective in patients with accelerated phase CML.

Improved three-year disease-free and recurrence-free survival seen with intensive chemotherapy regimen. HealthDay News — For patients with operative triple-negative breast cancer, a multigene ...

Higher peak doses were associated with inferior progression-free survival and overall survival. Cancer patients may fare better if they receive lower corticosteroid doses to treat immune-related ...

Researchers sought to determine whether a low dose of bosutinib followed by escalation would be effective for patients with CML.

Researchers identified risk factors for postoperative nausea and vomiting in patients with lung cancer who underwent thoracoscopic surgery.

Higher Healthy Eating Index score linked to significantly lower risk for grade reclassification in men undergoing active surveillance.

Patients with early breast cancer who are at risk of late relapse after breast-conserving surgery may derive little benefit from adjuvant radiotherapy, research suggests.

Researchers investigated whether naldemedine could help prevent opioid-induced constipation among patients with cancer.

One week after high-dose methotrexate treatment, plasma citrulline levels dropped to median levels of 14.5 μM for patients treated according to a particular protocol and to 16.9 μM according to the ...

A review of data demonstrated that female patients with MM experience worse adverse effects, PFS, and OS with higher treosulfan doses, compared with male patients.

Researchers compared the efficacy of various treatment modalities for cutaneous squamous cell carcinoma in situ.